Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02122172
Title Afatinib in Advanced Refractory Urothelial Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Chicago
Indications

urethra transitional cell carcinoma

ureter transitional cell carcinoma

bladder urothelial carcinoma

Therapies

Afatinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Winship Cancer Institute Recruiting Atlanta Georgia 30322 United States Details
University of Chicago Recruiting Chicago Illinois 60637 United States Details
Decatur Memorial Hospital Recruiting Decatur Illinois 62526 United States Details
NorthShore University Health System Completed Evanston Illinois 60201 United States Details
NYU Langone Health Recruiting New York New York 10016 United States Details
University of North Carolina - Lineberger Comprehensive Cancer Center Recruiting Chapel Hill North Carolina 27599 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field